RNF146PARP1

Liuye Yang1,2, Meng Du1,2,3,4, Kaiyuan Liu1,2

  • 1Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

PubMed
概括

一种新型化合物皮内林通过抑制巨细胞炎症来对抗败血症. 它针对Poly (ADP-ribose) 聚合酶1 (PARP1) 的激活,并促进其降解,为败血症提供了新的治疗策略.